Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in paediatric and adolescent Crohn’s disease: an observational study
2025-524129-42-00Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methotrexate in Crohn's disease (2 arms), sponsored by Amsterdam University Medical Center. Planned start Jul 2026; status: authorised.
02
Drugs
methotrexate
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2025-524129-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524129-42-00.